Berry M N, Grivell A R, Grivell M B, Phillips J W
Department of Medical Biochemistry, School of Medicine, Faculty of Health Sciences, Flinders University of South Australia, Adelaide, Australia.
Cell Biol Toxicol. 1997 Jul;13(4-5):223-33. doi: 10.1023/a:1007402505482.
The first technique for large-scale preparation of isolated hepatocytes was described in 1953 and involved perfusion of rat liver under pressure with a Ca(2+)-free solution containing a chelating agent. Various modifications of this technique were in use over the next ten years, until it was demonstrated that cells prepared in this manner were grossly damaged, losing most of their cytoplasmic enzymes during the preparative procedure. The successful preparation of intact isolated hepatocytes by collagenase-treatment of liver was achieved in 1967, and the widespread use of intact hepatocyte suspensions was accelerated by the development soon after of high-yield preparative techniques involving perfusion of the liver with a medium containing collagenase. The introduction of the isolated hepatocyte preparation has enabled experimental studies that otherwise would not be feasible. Important advances have been the use of cultured hepatocytes, frequently of human origin, for the investigation of the metabolism and toxicology of potential therapeutic agents. Success in this field has been achieved through the steady improvement in techniques for the maintenance in culture of differentiated hepatocytes, and in particular their cytochrome P450 complexes. Another area showing considerable promise is the employment of hepatocytes, generally from a porcine source, in temporary support systems for patients with acute liver failure. Our own studies have concentrated on the demonstration of long-range interactions between hepatocyte compartments which suggest that energy transfer between cell compartments can take place without ATP turnover.
1953年描述了第一种大规模制备分离肝细胞的技术,该技术涉及用含有螯合剂的无钙溶液在压力下灌注大鼠肝脏。在接下来的十年中,对该技术进行了各种改进,直到有研究表明以这种方式制备的细胞受到严重损伤,在制备过程中失去了大部分细胞质酶。1967年通过用胶原酶处理肝脏成功制备了完整的分离肝细胞,并且在不久之后开发出了用含有胶原酶的培养基灌注肝脏的高产制备技术,这加速了完整肝细胞悬液的广泛应用。分离肝细胞制剂的引入使得原本不可行的实验研究成为可能。重要的进展包括使用经常来源于人类的培养肝细胞来研究潜在治疗药物的代谢和毒理学。通过不断改进分化肝细胞(特别是其细胞色素P450复合物)的培养技术,该领域取得了成功。另一个显示出巨大潜力的领域是将通常来源于猪的肝细胞用于急性肝衰竭患者的临时支持系统。我们自己的研究集中在证明肝细胞区室之间的远程相互作用,这表明细胞区室之间的能量转移可以在没有ATP周转的情况下发生。